These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Serotonin syndrome from fluvoxamine and buspirone. Baetz M; Malcolm D Can J Psychiatry; 1995 Sep; 40(7):428-9. PubMed ID: 8548727 [No Abstract] [Full Text] [Related]
23. Sulpiride addition in a case of fluvoxamine-refractory obsessive-compulsive disorder without comorbid psychopathology. Sevincok L; Uslu A; Kaynak H; Dereboy F J Psychiatry Neurosci; 2000 Mar; 25(2):185. PubMed ID: 10740992 [No Abstract] [Full Text] [Related]
24. Fluvoxamine treatment of obsessive-compulsive disorder. Perse TL; Greist JH; Jefferson JW; Rosenfeld R; Dar R Am J Psychiatry; 1987 Dec; 144(12):1543-8. PubMed ID: 3120604 [TBL] [Abstract][Full Text] [Related]
25. Compulsive exhibitionism successfully treated with fluvoxamine: a controlled case study. Zohar J; Kaplan Z; Benjamin J J Clin Psychiatry; 1994 Mar; 55(3):86-8. PubMed ID: 8071253 [TBL] [Abstract][Full Text] [Related]
26. Obsessive-compulsive disorder. George MS Int Clin Psychopharmacol; 1991 Dec; 6 Suppl 3():57-66; discussion 66-8. PubMed ID: 1806635 [TBL] [Abstract][Full Text] [Related]
27. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. McDougle CJ; Goodman WK; Leckman JF; Lee NC; Heninger GR; Price LH Arch Gen Psychiatry; 1994 Apr; 51(4):302-8. PubMed ID: 8161290 [TBL] [Abstract][Full Text] [Related]
29. Controlled-release fluvoxamine in obsessive-compulsive disorder and social phobia. Owen RT Drugs Today (Barc); 2008 Dec; 44(12):887-93. PubMed ID: 19198698 [TBL] [Abstract][Full Text] [Related]
30. Fluvoxamine gains approval for obsessive-compulsive disorder. Am J Health Syst Pharm; 1995 Feb; 52(4):355. PubMed ID: 7757852 [No Abstract] [Full Text] [Related]
31. Seizures induced by combined levomepromazine-fluvoxamine treatment. Grinshpoon A; Berg Y; Mozes T; Mester R; Weizman A Int Clin Psychopharmacol; 1993; 8(1):61-2. PubMed ID: 8473723 [TBL] [Abstract][Full Text] [Related]
32. Treatment of severe obsessive-compulsive disorder with fluvoxamine. Price LH; Goodman WK; Charney DS; Rasmussen SA; Heninger GR Am J Psychiatry; 1987 Aug; 144(8):1059-61. PubMed ID: 3111279 [TBL] [Abstract][Full Text] [Related]
33. Response to risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases. Berigan TR; Harazin JS J Clin Psychiatry; 1996 Dec; 57(12):594-5. PubMed ID: 9010126 [No Abstract] [Full Text] [Related]
34. Specificity of serotonin reuptake inhibitors in the treatment of obsessive-compulsive disorder. Comparison of fluvoxamine and desipramine. Goodman WK; Price LH; Delgado PL; Palumbo J; Krystal JH; Nagy LM; Rasmussen SA; Heninger GR; Charney DS Arch Gen Psychiatry; 1990 Jun; 47(6):577-85. PubMed ID: 2112374 [TBL] [Abstract][Full Text] [Related]
35. Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder. Go FS; Malley EE; Birmaher B; Rosenberg DR J Child Adolesc Psychopharmacol; 1998; 8(1):73-80. PubMed ID: 9639082 [TBL] [Abstract][Full Text] [Related]
36. Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial. Bogetto F; Bellino S; Vaschetto P; Ziero S Psychiatry Res; 2000 Oct; 96(2):91-8. PubMed ID: 11063782 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review. Piccinelli M; Pini S; Bellantuono C; Wilkinson G Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913 [TBL] [Abstract][Full Text] [Related]
38. Fluvoxamine in the treatment of compulsive buying. Black DW; Monahan P; Gabel J J Clin Psychiatry; 1997 Apr; 58(4):159-63. PubMed ID: 9164426 [TBL] [Abstract][Full Text] [Related]
39. Hair loss associated with fluvoxamine use. Parameshwar E Am J Psychiatry; 1996 Apr; 153(4):581-2. PubMed ID: 8599419 [No Abstract] [Full Text] [Related]